Inventor · disambiguated record
Elizabeth Jaffee
Also filed as: JAFFEE ELIZABETH · JAFFEE ELIZABETH M · JAFFEE ELIZABETH MARION
9 granted patents·7 pending applications·438 citations·filing 1996–2020
91Inventor score
Top patents by PatentIndex Score
16 records- 0190US6033674AMethod of treating cancer with a tumor cell line having modified cytokine expressionUNIV JOHNS HOPKINS MED·Filed 1996·Granted Mar 7, 2000·83 cites·17 claims
- 0289US6350445B1Method of treating cancer with a tumor cell line having modified cytokine expressionUNIV JOHNS HOPKINS MED·Filed 1999·Granted Feb 26, 2002·78 cites·17 claims
- 0389US5985290APurified pancreatic tumor cell lines and related compositions and methodUNIV JOHNS HOPKINS MED·Filed 1998·Granted Nov 16, 1999·69 cites·17 claims
- 0488US10792349B2Galectin-3 as immunological targetUNIV JOHNS HOPKINS·Filed 2016·Granted Oct 6, 2020·4 cites·10 claims
- 0587US5861159AControlled release of pharmaceutically active substances for immunotherapyUNIV JOHNS HOPKINS MED·Filed 1996·Granted Jan 19, 1999·94 cites·13 claims
- 0678US6193970B1Controlled release of pharmaceutically active substances for immunotherapyUNIV JOHNS HOPKINS MED·Filed 1998·Granted Feb 27, 2001·58 cites·27 claims
- 0778US6187306B1Melanoma cell lines expressing shared immunodominant melanoma antigens and methods of using sameUNIV JOHNS HOPKINS·Filed 1997·Granted Feb 13, 2001·51 cites·17 claims
- 0865US10398764B2Annexin A2 as immunological targetUNIV JOHNS HOPKINS·Filed 2014·Granted Sep 3, 2019·0 cites·6 claims
- 0965US2011293608A1Annexin a2 as immunological targetJAFFEE ELIZABETH MARION·Filed 2009·Application pending·0 cites
- 1062US2007059315A1Prostate stem cell antigen vaccines and uses thereofJAFFEE ELIZABETH M·Filed 2006·Application pending·0 cites
- 1160US2017258881A1Annexin a2 as immunological targetUNIV JOHNS HOPKINS·Filed 2017·Application pending·0 cites
- 1253US2011243972A1Prostate stem cell antigen vaccines and uses thereofUNIV JOHNS HOPKINS·Filed 2011·Application pending·0 cites
- 1352US2007142456A1Method for inhibiting cancer development by fatty acid synthase inhibitorsUNIV JOHNS HOPKINS·Filed 2003·Application pending·0 cites
- 1448US2022267274A1Targeting ptpn22 in cancer therapyUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 1537US2017106067A1Combinatorial immunotherapy for pancreatic cancer treatmentUNIV JOHNS HOPKINS·Filed 2015·Application pending·0 cites
- 1635US6087174AGrowth medium for primary pancreatic tumor cell cultureUNIV JOHNS HOPKINS MED·Filed 1998·Granted Jul 11, 2000·1 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Elizabeth Jaffee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →